Chongqing Jiheng Pharmaceutical Co., Ltd. (SHE:002742)
China · Delayed Price · Currency is CNY 3.630
+0.040 (1.11%)
Oct 23, 2026, 3:04 PM CST
SHE:002742 Revenue
Chongqing Jiheng Pharmaceutical had revenue of 98.82M CNY in the quarter ending June 30, 2026, a decrease of -60.70%. This brings the company's total for the last twelve months to 654.22M, down -30.87% year-over-year. In the year 2025, Chongqing Jiheng Pharmaceutical had annual revenue of 899.85M, down -24.74%. That makes Chongqing Jiheng Pharmaceutical the 22,797th largest company in the world by revenue and 4,155th in China.
Revenue (ttm)
654.22M
Revenue Growth
-30.87%
P/S Ratio
3.80
Revenue / Employee
668.25K
Employees
979
Market Cap
2.48B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:002742 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 899.85M | -295.87M | -24.74% |
| Dec 31, 2024 | 1.20B | -834.52M | -41.10% |
| Dec 31, 2023 | 2.03B | -46.79M | -2.25% |
| Jan 1, 2023 | 2.08B | -412.12M | -16.56% |
| Jan 1, 2022 | 2.49B | -60.36M | -2.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.50B |
| Guizhou Yibai Pharmaceutical | 1.56B |
| Shaanxi Panlong Pharmaceutical Group | 989.42M |
| Zhejiang Shengda Bio-Pharm | 832.86M |
| Jiangxi Synergy Pharmaceutical | 784.40M |
| Hainan Huluwa Pharmaceutical Group | 634.04M |
| Chengdu huasun technology group Inc. , LTD. | 486.70M |
| Honz Pharmaceutical | 378.56M |